Movano Inc. (MOVE)
Market Cap | 30.07M |
Revenue (ttm) | 852,000 |
Net Income (ttm) | -27.91M |
Shares Out | 98.27M |
EPS (ttm) | -0.55 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 167,208 |
Open | 0.300 |
Previous Close | 0.291 |
Day's Range | 0.280 - 0.318 |
52-Week Range | 0.240 - 1.500 |
Beta | 0.17 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Aug 12, 2024 |
About MOVE
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and c... [Read more]
Financial Performance
Financial StatementsNews
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2024 /PRNewswire/ -- Movano Healt...
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif., June 13, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announ...
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease
Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif.
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference ...
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision
Unlocking business-to-business opportunities with Evie Med, Movano Health's ring pulse oximeter, remains a key priority for the Company. PLEASANTON, Calif.
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., May 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report first quarte...
Movano Health Closes $24 Million Private Placement
Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of Movano Health's management team and board of...
Movano Health Reports 2023 Financial Results and Provides Business Update
Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT/ 5:00 PM ET T...
Movano Health Announces $24 Million Private Placement
Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting ...
Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company
The seed investment and agreement underscores Movano Health's multi-analyte and proprietary mmWave radio frequency technology PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq:...
Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth qu...
Movano Health Announces Evie Rings Now Shipping
PLEASANTON, Calif. , Jan. 22, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced that its female first wearable, the Evie Ring, will begin shipping today.
Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women
LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams O...
Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level
Movano Health's 2024 CES Innovation Honoree Ships This Month LAS VEGAS , Jan. 8, 2024 /PRNewswire/ -- The Evie Ring from Movano Health (Nasdaq: MOVE), the market's first women-focused smart ring, is r...
Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring
PLEASANTON, Calif. , Dec. 18, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that its female first wearable, the Evie Ring, is now eligible for HSA/...
Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement
PLEASANTON, Calif. , Dec. 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clin...
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
PLEASANTON, Calif. , Nov. 29, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ...
Evie, the Smart Ring for Women from Movano Health, Available for Order Today
Unique Design, Women-Focused Metrics and Cross-Data Trend Analysis Set a New Bar for Wearables PLEASANTON, Calif. , Nov. 20, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) begins taking orders for ...
Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option
PLEASANTON, Calif. , Nov. 17, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and con...
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
Conference call begins at 8:30 a.m. Pacific time today PLEASANTON, Calif.
Movano Health Prices $3.6 Million Public Offering
PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and con...
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023
Reschedules Q3 results conference call to 11:30 am EST on November 15, 2023 PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare ...
Movano Health Announces Proposed Public Offering
PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and con...
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
PLEASANTON, Calif. , Nov. 3, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and mak...
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring
Leveraging the Company's 4 x 6.7 mm System-on-a-Chip (SoC), the clinical study results are a significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure device ...